The American Orthopaedic Society for Sports Medicine has awarded Dr. Alex Scott and his team a grant to study a potential treatment for patellar tendinopathy. Their review panel is very enthusiastic about this study and believes it has extremely high potential to provide important and timely information that could significantly impact clinical practice.
“Intratendinous injections of platelet‐poor plasma, or platelet rich plasma with or without leukocyte enrichment for patellar tendinopathy: a multi‐centre, double‐blind, randomized controlled trial” will be conducted over the next two years. Athletes with chronic patellar tendinopathy will be recruited from four international sites and randomized into one of four study groups and will be followed for 1 year. The team will study the effect of platelet-rich plasma (PRP) and its major components (plasma, platelets, leukocytes) on recovery of pain and function. Additionally this research will guide decision making around the most effective plasma preparation methods.